SCHEMBL15200218

SCHEMBL15200218

Cc1cccc(OC(=O)c2cccs2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 11/20 0.61
MAPT P10636 4/20 0.61
ALDH1A1 P00352 4/20 0.61
GAA P10253 3/20 0.61
CYP1A2 P05177 3/20 0.61
CYP2C19 P33261 3/20 0.61
CYP3A4 P08684 2/20 0.61
PLA2G1B P04054 2/20 0.60
ATG4B Q9Y4P1 2/20 0.60
TDP1 Q9NUW8 2/20 0.60
L3MBTL1 Q9Y468 2/20 0.56
HPGD P15428 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
LMNA P02545 2/20 0.56
NPC1 O15118 1/20 0.56
PKM P14618 1/20 0.56
RAB9A P51151 1/20 0.56
POLB P06746 2/20 0.55
ALOX15 P16050 1/20 0.55
TSHR P16473 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8544512 0.82 LMNA (0.61) KMT2AMAPTALDH1A1GAACYP1A2
SCHEMBL15200217 0.82 KMT2A (0.71) KMT2AMAPTALDH1A1GAACYP1A2
SCHEMBL6624505 0.81 KMT2A (0.55) KMT2AMAPTALDH1A1GAAPLA2G1B
SCHEMBL12768208 0.81 PLA2G1B (0.64) KMT2AMAPTALDH1A1GAACYP1A2
SCHEMBL4810433 0.80 KMT2A (0.68) KMT2AMAPTALDH1A1GAAPLA2G1B
Iodide SCHEMBL30758523 0.78 KMT2A (0.66) KMT2AMAPTALDH1A1GAAPLA2G1B
SCHEMBL19002849 0.78 LMNA (0.56) KMT2AMAPTALDH1A1GAACYP1A2
SCHEMBL2126821 0.78 KMT2A (0.52) KMT2AMAPTALDH1A1GAAPLA2G1B
SCHEMBL8544516 0.77 LMNA (0.54) KMT2AMAPTALDH1A1GAACYP1A2
SCHEMBL6267989 0.77 LMNA (0.54) KMT2AMAPTALDH1A1GAAPLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962244-B2 Compounds for modulating RNA binding proteins and uses therefor UNIVERSITY OF MASSACHUSETTS (US) 2015-02-24 US disclosed
US-20130217685-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR UNIVERSITY OF MASSACHUSETTS (US) 2013-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217685-A1 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR TIA1, ZFP3, RBM3 KMT2A 3013/4885MAPT 4038/4885ALDH1A1 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.